Tevogen Bio Holdings Inc. (TVGN)
Develops ready-made T cell therapies to treat cancer, infections, and immune disorders.
$5.24-0.06%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-89.5%
The outlook
TVGN is trading near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, suggesting a downtrend. Analyst coverage appears thin or unavailable. The overall data setup leans bearish based on current price positioning and trend weakness.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$22.1M
52-wk high
$70.00
52-wk low
$3.64
50-day avg
$7.71
200-day avg
$14.07
Trailing P/E
—